CSF2 and chronic myelogenous leukemia, BCR-ABL1 positive: In this light, introduction of the gene encoding granulocyte/macrophage-colony stimulating factor (GM-CSF) into CML-DC may be an attractive approach to both enhance and prolong antigen presentation and thus promote antileukaemic responses (Thomas et al, 1998).